NFKB1 and rheumatoid arthritis: conjugated 9-aminoacridine and caffeic acid to mPEG-PCL nanomicelles (9AA-NMs) to effectively treat RA by inhibiting NF-κB and HIF-1α, mitigating the inflammatory cascade, and ultimately preventing cartilage erosion, swelling, and joint damage [261].